Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Research Area
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

MX69 is an inhibitor of the interaction between the ubiquitin ligase MDM2 protein and XIAP mRNA.1 It binds to the RING domain of MDM2 (Kd = 2.34 µM) and decreases the levels of MDM2 and XIAP in a concentration-dependent manner without affecting the levels of Bcl-2, cIAP-1, and cIAP-2. It induces autoubiquitination and degradation of MDM2 and increases the half-life of p53 in EU-1 cells. MX69 is cytotoxic to a variety of acute lymphoblastic leukemia (ALL) and neuroblastoma cancer cell lines but not to human normal bone marrow mononuclear (NBMM) cells. It increases survival in an EU-1 mouse model of leukemia when administered at a dose of 100 mg/kg.
WARNING This product is not for human or veterinary use.
1. Discovery of dual inhibitors of MDM2 and XIAP for cancer treatment. Cancer Cell 30(4), 623-636 (2016).